Apolo Biotech
PrivateLast Round
Grant
Oct 22, 2025
Total Funding Raised
$2.16M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Apolo Biotech operates in Energy & Sustainability and is based in Santa Fe. Its latest recorded funding round was a Grant round in October 2025.
Apolo Biotech is an agricultural biotechnology company that develops RNA-based technologies for crop improvement and pest control.
Sector
Energy & Sustainability
Verticals
Biotechnology, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Apolo Biotech Comparables
Compare Apolo Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RNAissance Ag | 84% | |
| Trillium Ag | 81% | |
| Omerna Biosolutions | 80% |
For institutional investors. Book with your work email.
Apolo Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 22, 2025 | ||||
| SAFE | Oct 16, 2025 | ||||
| Grant | Oct 14, 2025 | ||||
| Grant | May 15, 2025 | ||||
| Grant | May 9, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Apolo Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EIT Food | SAFE |
| Santander X | Grant |
| Breakthrough Energy Discovery | Grant |
| BioSTL | Grant |
| Core Facilities Access Fund | Grant |
| The Yield Lab Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 12, 2026
Web traffic grew 1856% MoM (from 110 to 2.2K monthly visitors)
- Sep 14, 2026
Monthly visitors increased 31% MoM.
For institutional investors. Book with your work email.
Apolo Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Apolo Biotech's valuation, stock price, and market status.
Is Apolo Biotech a public or private company?
Apolo Biotech is a private company.
What is the current stock price of Apolo Biotech?
Apolo Biotech is a private company, so its shares have no public market price. Caplight tracks Apolo Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Apolo Biotech worth (valuation)?
Valuation information for Apolo Biotech is not publicly available.
Can I buy Apolo Biotech stock?
Apolo Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Apolo Biotech's last funding round?
Apolo Biotech's most recent funding round was Grant on October 22, 2025.
Who are the main investors in Apolo Biotech?
Key investors in Apolo Biotech include EIT Food, Santander X, Breakthrough Energy Discovery, BioSTL, Core Facilities Access Fund.
Will Apolo Biotech IPO soon?
No public IPO plans have been announced for Apolo Biotech.
How can I track Apolo Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Apolo Biotech's shares on secondary markets.